Active Ingredient History

NOW
  • Now
Oxethazaine is a potent local anesthetic. It is administered orally (usually in combination with an antacid) for the relief of pain associated with peptic ulcer disease or esophagitis. Its effectiveness at the acidity of the gastric environment is due to the fact that oxethazaine, a weak base, is relatively non-ionized at pH 1. It is also used topically in the management of hemorrhoid pain. Oral oxetacaine preparations are available in several countries, including India, South Africa and Brazil, but not the United States. It is marketed under the name Strocain in Japan.   NCATS

  • SMILES: CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1=CC=CC=C1)C(C)(C)CC2=CC=CC=C2
  • InChIKey: FTLDJPRFCGDUFH-UHFFFAOYSA-N
  • Mol. Mass: 467.6434
  • ALogP: 3.24
  • ChEMBL Molecule:
More Chemistry
2,2'-((2-hydroxyethyl)imino)bis(n-alpha,alpha-dimethylphenethyl)-n-methylacetamide | mucaine | mucoxin | muthesa | oxaine | oxetacain | oxetacaine | oxethazaine | oxethazaine hydrochloride | oxethazaine monohydrochloride | oxethazine | robercain r | storocain | storocaine | strocain | tepilta | wy-806

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue